Home » Stocks » RTTR

Ritter Pharmaceuticals, Inc. (RTTR)

May 26, 2020 - RTTR merged into QLGN
Stock Price: $0.448 USD 0.000 (0.00%)
Updated May 22, 2020 4:00 PM EDT
Market Cap 827,061
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 46.15M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 22, 2020
Last Price $0.448
Previous Close $0.448
Change ($) 0.000
Change (%) 0.00%
Day's Open -
Day's Range 0.440 - 0.540
Day's Volume 17,888,966
52-Week Range 0.150 - 1.270

News

Hide News
GlobeNewsWire - 8 months ago

LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger trans...

GlobeNewsWire - 8 months ago

LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vo...

GlobeNewsWire - 8 months ago

LOS ANGELES, May 14, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter” or the “Company”), today announced that it has adjourned its special meeting of stockholde...

GlobeNewsWire - 8 months ago

LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice fro...

GlobeNewsWire - 8 months ago

LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services...

GlobeNewsWire - 8 months ago

LOS ANGELES, May 01, 2020 (GLOBE NEWSWIRE) -- Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway

GlobeNewsWire - 8 months ago

The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split.

GlobeNewsWire - 9 months ago

Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders  to Vote on Proposed Merger Scheduled for May 14, 2020

GlobeNewsWire - 9 months ago

Definitive merger agreement with Qualigen, Inc. announced in January 2020

GlobeNewsWire - 1 year ago

Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs

GlobeNewsWire - 1 year ago

LOS ANGELES, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the ...

Benzinga - 1 year ago

Shares of thinly-trade Ritter Pharmaceuticals Inc (NASDAQ: RTTR) are plunging to an all-time low Friday morning following a clinical readout.

GlobeNewsWire - 1 year ago

LOS ANGELES, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that m...

About RTTR

Ritter Pharmaceuticals develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, Californi... [Read more...]

Industry
Biotechnology
IPO Date
Jun 24, 2015
CEO
Andrew J. Ritter
Employees
5
Stock Exchange
NASDAQ
Ticker Symbol
RTTR
Full Company Profile